Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1999-06-25
2000-10-31
Sisson, Bradley L.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530330, 530350, A61K 3800, A61K 3804, C07K 100
Patent
active
061404659
ABSTRACT:
A murine cDNA clone encoding a BIN1-Associated U1-specific protein (Bau) are provided. Also provided are methods of using the nucleic acid sequences, polypeptides, and antibodies directed against same in the diagnosis and treatment of cancers, hyperplastic disease states, or degenerative diseases.
REFERENCES:
patent: 5605830 (1997-02-01), Prendergast
patent: 5723581 (1998-03-01), Prendergast
M.D. Cole, "The myc Oncogene: its Role in Transformation and Differentiation," Ann. Rev. Genet., 20:361-384 (1986).
Evan and Littlewood, "The Role of c-myc in Cell Growth," Curr. Opin. Genet. Dev., 3:44-49 (1993).
M. Eilers et al., "Chimaeras of Myc Oncoprotein and Steroid Receptors Cause Hormone-Dependent Transformation of Cells", Nature, 340:66-68 (Jul. 6, 1989).
R. Heikkila et al., "A c-myc Antisense Oligodeoxynucleotide Inhibits Entry into S Phase but not Progress from G.sub.0 to G.sub.1," Nature, 328:445-448 (Jul. 30, 1987).
J.T. Holt et al., "An Oligomer Complementary to c-myc mRNA Inhibits Proliferation of HL-60 Promyelocytic Cells and Induces Differentiation," Mol. Cell. Biol., 8:963-973 (Feb. 1988).
K.D. Hanson et al., "Effects of c-myc Expression of Cell Cycle Progression," Mol. Cell. Biol., 14:5748-5755 (Sep. 1994).
D.S. Askew et al., "Constitutive c-myc Expression in an IL-3-dependent Myeloid Dell Line Suppresses Cell Cycle Arrest and Accelerates Apoptosis," Oncogene, 6:1915-1922 (Oct. 1991).
G.I. Evan et al., "Induction of Apoptosis in Fibroblasts by c-myc Protein," Cell, 69:119-128 (Apr. 3, 1992).
D. Sakamuro et al., "c-Myc Induces Apoptosis in Epithelial Cells by Both p53-dependent and p53-independent Mechanisms," Oncogene, 11:2411-2418 (1995).
A. Levine, "The Tumor Suppressor Genes," Ann. Rev. Biochem., 62:623-651 (1993).
D. Sakamuro et al., "BIN1 is a Novel Myc-Interacting Protein with Features of a Tumor Suppressor," Nature Genet., 14:69-77 (Sep. 14, 1996).
D. Negorev et al., "The Bin1 Gene Localizes to Human Chromosome 2q14 by PCR Analysis of Somatic Cell Hybrids and Fluorescence in Situ Hybridization," Genomics, 33:329-331 (Apr. 1996).
M.L. Cher et al., "Genetic Alterations in Untreated Metastases and Androgen-independent Prostate Cancer Detected by Comparative Genomic Hybridization and Allelotyping," Cancer Res., 56:3091-3102 (Jul. 1, 1996).
R. Wechsler-Reya et al., "The Putative Tumor Suppressor BIN1 is a Short-Lived Nuclear Phosphoprotein, the Localization of which is Altered in Malignant Cells," Cancer Res., 57:3258-3263 (Aug. 1, 1997).
Hardwick and Murray, "Mad 1 p, a Phosphoprotein Component of the Spindle Assembly Checkpoint in Budding Yeast," J. Cell. Bio., 131:709-720 (Nov. 1995).
T. Hudson, "Human STSs Derived from Sequences in dbEST and the Unigene Collection", Database on MPSRCH, Genbank, Accession No. G24494 (1995).
G. Prendergast et al., "A New Bind for Myc," TIG, 9(3):91-97 (Mar. 1992).
A. Ritonja et al., "Amino Acid Sequence of the Intracellular Cysteine Proteinase Inhibitor Cystatin B from Human Liver," Biochem. Biophys. Res. Comm., 131(3):1187-1192 (Sep. 30, 1985).
Molecular Sigma Biology (catalog), p. 54 (1985).
Sisson Bradley L.
The Wistar Institute of Anatomy and Biology
LandOfFree
Bau, a BIN1 interacting protein, and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bau, a BIN1 interacting protein, and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bau, a BIN1 interacting protein, and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2053285